Publications / Publikace

  1. Catalano C.; da Silva Filho M.I.; Frank C.; Lu Shun; Jirásková K.; Vymetálková V.; Levý M.; Liška V.; Vyčítal O.; Naccarati A.; Vodičková L.; Hemminki K.; Vodička P.; Weber A. N R; Försti A.: Epistatic effect of TLR3 and cGAS-STING-IKKε-TBK1-IFN signaling variants on colorectal cancer risk. Cancer Med. 2020 Feb;9(4):1473-1484. doi: 10.1002/cam4.2804.
  2. Chattopadhyay, S., H. Thomsen, N. Weinhold, I. Meziane, S. Huhn, M. I. da Silva Filho, P. Vodicka, L. Vodickova, P. Hoffmann, M. M. Nothen, K. H. Jockel, B. Schmidt, S. Landi, R. Hajek, G. Hallmans, U. Pettersson-Kymmer, C. Ohlsson, P. Milani, G. Merlini, D. Rowcieno, P. Hawkins, U. Hegenbart, G. Palladini, A. Wechalekar, S. O. Schonland, R. Houlston, H. Goldschmidt, K. Hemminki, and A. Forsti. "Eight Novel Loci Implicate Shared Genetic Etiology in Multiple Myeloma, Al Amyloidosis, and Monoclonal Gammopathy of Unknown Significance." Leukemia 34, no. 4 (Apr 2020): 1187-91. https://dx.doi.org/10.1038/s41375-019-0619-1.
  3. Chattopadhyay, S., G. Zheng, A. Hemminki, A. Forsti, K. Sundquist, J. Sundquist, and K. Hemminki. "Influence of Family History on Risk of Second Primary Cancers and Survival in Patients with Squamous Cell Skin Cancer." Br J Dermatol (Dec 19 2019). https://dx.doi.org/10.1111/bjd.18809.
  4. Pertesi, M., M. Went, M. Hansson, K. Hemminki, R. S. Houlston, and B. Nilsson. "Genetic Predisposition for Multiple Myeloma." Leukemia 34, no. 3 (Mar 2020): 697-708. https://dx.doi.org/10.1038/s41375-019-0703-6.
  5. Srinivas, N., N. Neittaanmaki, B. Heidenreich, S. Rachakonda, T. T. Karppinen, M. Gronroos, T. T. Tani, M. Salmivuori, E. Snellman, K. Hemminki, and R. Kumar. "Tert Promoter Mutations in Actinic Keratosis before and after Treatment." Int J Cancer 146, no. 10 (May 15 2020): 2932-34. https://dx.doi.org/10.1002/ijc.32878.
  6. Srivastava, A., S. Giangiobbe, A. Kumar, N. Paramasivam, D. Dymerska, W. Behnisch, M. Witzens-Harig, J. Lubinski, K. Hemminki, A. Forsti, and O. R. Bandapalli. "Identification of Familial Hodgkin Lymphoma Predisposing Genes Using Whole Genome Sequencing." Front Bioeng Biotechnol 8 (2020): 179. https://dx.doi.org/10.3389/fbioe.2020.00179.
  7. Zheng, G., S. Chattopadhyay, K. Sundquist, J. Sundquist, A. Forsti, A. Hemminki, and K. Hemminki. "Association between Tumor Characteristics and Second Primary Cancers with Cutaneous Melanoma Survival: A Nationwide Cohort Study." Pigment Cell Melanoma Res (Feb 3 2020). https://dx.doi.org/10.1111/pcmr.12868.
  8. Zheng, G., S. Chattopadhyay, K. Sundquist, J. Sundquist, A. Forsti, A. Hemminki, and K. Hemminki. "Second Primary Cancers in Melanoma Patients Critically Shorten Survival." Clin Epidemiol 12 (2020): 105-12. https://dx.doi.org/10.2147/clep.S230149.

Contact

Charles University
Faculty of Medicine in Pilsen
Biomedical Center

alej Svobody 1655/76
323 00 Plzeň – Severní Předměstí

T: +420 377 593 810
E: This email address is being protected from spambots. You need JavaScript enabled to view it.

Login

Log in to your account or Create an account